2018 | | Disease-specific impairment of the quality of life in adult patients with chronic spontaneous urticaria | 박해심, 반가영, 신유섭, 예영민 |
2020 | | Distinct functions of eosinophils in severe asthma with type 2 phenotype: clinical implications | 박해심, 최영우 |
2021 | | Distribution and quality of life in patients with primary immunodeficiency diseases in a cohort of Korean adults | 박해심, 예영민 |
2019 | | Does Changing Inhaler Device Impact Real-Life Asthma Outcomes? Clinical and Economic Evaluation | 박해심 |
2013 | | Double-filtration plasmapheresis for the treatment of patients with recalcitrant atopic dermatitis. | 남동호, 박준성 |
2022 | | Down-regulated surfactant protein B in obese asthmatics | 김승현, 박해심 |
2017 | | Drug-specific CD4(+) T-cell immune responses are responsible for antituberculosis drug-induced maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms syndrome | 김승현, 박해심, 반가영, 예영민 |
2018 | | Dupilumab efficacy in asthma patients with comorbid chronic rhinosinusitis or nasal polyposis (CRS/NP) in LIBERTY ASTHMA QUEST | 박해심 |
2020 | | Dupilumab Efficacy in Patients Stratified by Baseline Treatment Intensity and Lung Function | 박해심 |
1995 | | Early and late onset asthmatic responses following lysine-aspirin inhalation in aspirin-sensitive asthmatic patients. | 박해심 |
2012 | | Effect of genetic polymorphism of ALOX15 on aspirin-exacerbated respiratory disease | 김승현, 박해심 |
2012 | | Effect of interleukin-18 gene polymorphisms on sensitization to wheat flour in bakery workers | 김승현, 박해심 |
2021 | | Effect of omalizumab as add-on therapy to quality of life questionnaire for korean asthmatics (Kaqlq) in korean patients with severe persistent allergic asthma | 박해심 |
2010 | | Effect of single nucleotide polymorphisms within the interleukin-4 promoter on aspirin intolerance in asthmatics and interleukin-4 promoter activity. | 박해심 |
2021 | | Effect of TGF-β1 on eosinophils to induce cysteinyl leukotriene E4 production in aspirin-exacerbated respiratory disease | 박해심, 신유섭, 최영우 |
2011 | | Effect of Toll-like receptor 4 gene polymorphisms on work-related respiratory symptoms and sensitization to wheat flour in bakery workers. | 김승현, 박해심 |
2022 | | Effectiveness of Maintenance and Reliever Therapy Using Inhaled Corticosteroid–Formoterol in Asthmatics | 박래웅, 박해심, 이영수, 장재혁 |
2023 | | Effects of COVID-19 and Influenza Vaccination on Rheumatic Diseases: Results From a Survey of Patient-Reported Outcomes After Vaccination | 김지원, 김현아, 서창희, 예영민, 정주양 |
2017 | | Effects of Immunoglobulin Replacement on Asthma Exacerbation in Adult Asthmatics with IgG Subclass Deficiency | 박해심, 반가영, 신유섭, 예영민 |
2015 | | Effects of Intramuscular Injection of Autologous Immunoglobulin on Clinical Severity and Serum IgE Concentration in Patients with Atopic Dermatitis. | 남동호 |
2015 | | Effects of MBL2 polymorphisms in patients with diisocyanate-induced occupational asthma. | 김승현, 박해심, 예영민 |
2012 | | Effects of omalizumab treatment in patients with refractory chronic urticaria | 박해심, 신유섭, 예영민 |
2020 | | Efficacy and Safety of a Pressurized Metered-Dose Inhaler in Older Asthmatics: Comparison to a Dry Powder Inhaler in a 12-Week Randomized Trial | 박주헌, 박해심, 신유섭, 예영민, 우성대, 이영수 |
2019 | | Efficacy and Safety of Benralizumab for Korean Patients With Severe, Uncontrolled Eosinophilic Asthma | 박해심 |
2024 | | Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials | 예영민 |
2021 | | Efficacy and safety of mepolizumab in korean patients with severe eosinophilic asthma from the dream and mensa studies | 박해심 |
2017 | | Efficacy and safety of omalizumab in Japanese and Korean patients with refractory chronic spontaneous urticaria | 박해심, 예영민 |
2018 | | Efficacy and Safety of Sublingual Immunotherapy in Elderly Rhinitis Patients Sensitized to House Dust Mites | 박해심, 신유섭, 예영민 |
2020 | | Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma | 박해심 |
2020 | | Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma | 박해심 |
2020 | | Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthma | 박해심 |
2019 | | Efficacy and tolerability of desensitization in the treatment of delayed drug hypersensitivities to anti-tuberculosis medications | 김승현, 박해심, 신승수, 신유섭, 예영민, 이소희, 정윤정 |
2023 | | Efficacy of Second-Line Treatments in Chronic Urticaria Refractory to Standard Dose Antihistamines | 박해심, 신유섭, 예영민 |
2020 | | Efficacy, Safety, and Immunomodulatory Effect of the Intramuscular Administration of Autologous Total Immunoglobulin G for Atopic Dermatitis: A Randomized Clinical Trial | 남동호, 박해심, 신유섭, 예영민 |
2004 | | Eggplant anaphylaxis in a patient with latex allergy. | 박해심 |
2004 | | Elevated level of serum tryptase in a patient with exercise-inuced anaphylaxis | 남동호, 박해심, 서유진, 서창희, 예영민, 임선교, 최정희 |
2021 | | Elevated MRGPRX2 levels related to disease severity in patients with chronic spontaneous urticaria | 예영민 |
2014 | | Elevated platelet activation in patients with chronic urticaria: a comparison between aspirin-intolerant and aspirin-tolerant groups. | 김승현, 박해심, 신유섭, 유혜수 |
1998 | | Elevation of specific immunoglobulin A antibodies to both allergen and bacterial antigen in induced sputum from asthmatics. | 남동호, 박해심 |
2014 | | Embarking on a new journey with the allergy, asthma & immunology research. | 박해심 |
2022 | | Emerging Biomarkers Beyond Leukotrienes for the Management of Nonsteroidal Anti-inflammatory Drug (NSAID)-Exacerbated Respiratory Disease | 박해심 |
2022 | | Emerging Hop Japanese Pollinosis in Asia | 박해심 |
2023 | | Endocrine-disrupting chemical exposure augments neutrophilic inflammation in severe asthma through the autophagy pathway | 박해심, 신유섭, 유민숙, 최영우 |
2012 | | Endotoxin is not essential for the development of cockroach induced allergic airway inflammation | 신유섭 |
2023 | | Engineering bispecific T-cell engagers to deplete eosinophils for the treatment of severe eosinophilic asthma | 박해심 |
2019 | | Engineering of anti-human interleukin-4 receptor alpha antibodies with potent antagonistic activity | 김승현, 박해심, 정근옥 |
2021 | | Engineering of Humanized Antibodies Against Human Interleukin 5 Receptor Alpha Subunit That Cause Potent Antibody-Dependent Cell-Mediated Cytotoxicity | 박해심, 정근옥, 최영우 |
1999 | | Enhanced basophil histamine release and neutrophil chemotactic activity predispose grain dust-induced airway obstruction. | 남동호, 박해심 |
1998 | | Enhanced neutrophil chemotactic activity after bronchial challenge in subjects with grain dust-induced asthma. | 박해심 |
2003 | | Enhanced serum neutrophil chemotactic activity was noted in both early and late asthmatic responses during lysine-aspirin bronchoprovocation test in ASA-sensitive asthmatic patients. | 남동호, 박해심 |